Clinical Trials in Pennsylvania

Showing 1901-1920 of 9,383 trials

AGN-CognI.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients

NCT05375539

This study is to obtain acute dose safety and pharmacokinetics/pharmacodynamics (PK/PD) data in a dose-response trial in prostate cancer patients.

Prostate Cancer

Milton S. Hershey Medical Center12 participantsStarted May 2023

Hershey, Pennsylvania, United States

COMPLETEDNA46 miles

Multi-hospital Electronic Decision Support for Drug-associated Acute Kidney Injury

NCT06264752

This study is a randomized controlled trial at eight hospitals within the University of Pittsburgh Medical Center-UPMC system. The project will assess the efficacy of a clinical surveillance system augmented with near real-time predictive analytics to support a pharmacist-led intervention delivered to attending physicians (primary service) to reduce the progression and complications of drug-associated acute kidney injury (D-AKI) in hospitalized (non-ICU) adults.

Acute Kidney Injury

University of Pittsburgh698 participantsStarted Feb 2024

Altoona, Pennsylvania, United States • Farrell, Pennsylvania, United States • McKeesport, Pennsylvania, United States +5 more locations

AGN-CognI.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients

Multi-hospital Electronic Decision Support for Drug-associated Acute Kidney Injury

Find Trials by Condition in Pennsylvania

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

Treatment Monitoring in Autism Spectrum Disorder (ASD) in Children

Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older

Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation

A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy

Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria

Periprosthetic Fracture Registry (PPFx)

A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy

A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma